We are live on
!
Find out more
TI
tru Independence Portfolio holdings
AUM
$229M
1-Year Est. Return
22.02%
This Fund
S&P 500
This Quarter
Est. Return
+16.99%
1 Year Est. Return
+22.02%
3 Year Est. Return
+55.73%
5 Year Est. Return
+56.97%
10 Year Est. Return
–
AUM
$691M
AUM Growth
+$78M
(+13%)
Cap. Flow
+$88.8M
Cap. Flow
% of AUM
12.85%
Top 10 Holdings %
Top 10 Hldgs %
41.04%
Holding
960
New
207
Increased
181
Reduced
170
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$61.5M |
| 2 |
Schwab US Broad Market ETF
SCHB
|
+$54.4M |
| 3 |
iShares Core S&P US Growth ETF
IUSG
|
+$28.9M |
| 4 |
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
|
+$16.7M |
| 5 |
SPDR Gold Trust
GLD
|
+$9.38M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BMY.RT
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
|
+$49.3M |
| 2 |
iShares Core S&P US Value ETF
IUSV
|
+$29.8M |
| 3 |
Schwab International Equity ETF
SCHF
|
+$24.1M |
| 4 |
State Street SPDR S&P Biotech ETF
XBI
|
+$21.5M |
| 5 |
First Trust NYSE Arca Biotechnology Index Fund
FBT
|
+$10.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 28.66% |
| 2 | Miscellaneous | 22.99% |
| 3 | Technology | 9.15% |
| 4 | Healthcare | 8.01% |
| 5 | Financials | 6.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Dow Inc
DOW
$21.9B
| $5.42M | 0.78% |
132,892
-14,049
| -10% | -$514K |
|
27
Truist Financial
TFC
$63B
| $5.33M | 0.77% |
142,053
+56,698
| +66% | +$2.04M |
|
28
Kroger
KR
$35.8B
| $5.33M | 0.77% |
157,308
+950
| +0.6% | +$30.8K |
|
29
iShares Core MSCI Emerging Markets ETF
IEMG
$162B
| $5.31M | 0.77% |
+113,346
| New | +$5.06M |
|
30
General Motors
GM
$76.5B
| $5.25M | 0.76% |
207,536
+5,346
| +3% | +$130K |
|
31
United Parcel Service
UPS
$88.1B
| $5.19M | 0.75% |
46,696
-1,217
| -3% | -$121K |
|
32
Merck
MRK
$376B
| $5.11M | 0.74% |
69,239
+33,903
| +96% | +$2.55M |
|
33
iShares 7-10 Year Treasury Bond ETF
IEF
$42.2B
| $4.8M | 0.69% |
+39,389
| New | +$4.79M |
|
34
LyondellBasell Industries
LYB
$20.9B
| $4.66M | 0.67% |
70,825
-920
| -1% | -$54.8K |
|
|
BERY
35
DELISTED
Berry Global Group, Inc.
BERY
| $4.59M | 0.66% |
112,717
-610
| -0.5% | -$22.9K |
|
36
Boeing
BA
$166B
| $4.48M | 0.65% |
24,454
+1,284
| +6% | +$197K |
|
37
Weyerhaeuser
WY
$16.6B
| $4.36M | 0.63% |
194,095
-3,125
| -2% | -$63.2K |
|
38
Tyson Foods
TSN
$18.2B
| $4.26M | 0.62% |
71,355
+4,465
| +7% | +$271K |
|
39
FMC
FMC
$1.63B
| $4.22M | 0.61% |
42,330
-930
| -2% | -$85.8K |
|
40
Travelers Companies
TRV
$78.1B
| $3.99M | 0.58% |
35,015
+113
| +0.3% | +$11.9K |
|
41
FedEx
FDX
$76.8B
| $3.99M | 0.58% |
28,445
+2,703
| +11% | +$340K |
|
42
BP
BP
$112B
| $3.96M | 0.57% |
169,966
+9,752
| +6% | +$234K |
|
|
43
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.98B
| $3.75M | 0.54% |
30,121
-68,493
| -69% | -$10.7M |
|
44
UnitedHealth
UNH
$360B
| $3.68M | 0.53% |
12,480
-135
| -1% | -$38.7K |
|
45
First Trust Value Line Dividend Fund
FVD
$8.25B
| $3.62M | 0.52% |
119,276
+27,576
| +30% | +$820K |
|
46
VanEck Gold Miners ETF
GDX
$31.4B
| $3.62M | 0.52% |
+98,592
| New | +$3.24M |
|
47
Cisco
CSCO
$428B
| $3.6M | 0.52% |
77,227
-13,167
| -15% | -$577K |
|
48
Kimco Realty
KIM
$16B
| $3.6M | 0.52% |
280,275
-3,925
| -1% | -$43.7K |
|
49
Home Depot
HD
$317B
| $3.59M | 0.52% |
14,308
+1,416
| +11% | +$324K |
|
50
Allstate
ALL
$66.5B
| $3.54M | 0.51% |
36,544
-140
| -0.4% | -$13.8K |
|
Similar funds
IAAG
AAG
WCM
PPA
DCC
SWIM
PRRFG
CAIM
tru Independence's Q2 2020 Portfolio in Review
As of Q2 2020, tru Independence held 960 positions worth $691M, up 13% from $613M the previous quarter. Its ten largest holdings account for 41% of the portfolio.
tru Independence deployed $88.8M of net new capital in Q2 2020, opening 207 new positions and adding to 181 existing holdings. Its largest new stake was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
By sector, the portfolio is most concentrated in Energy at 29% of assets, up from 2.8% a quarter earlier, followed by Miscellaneous and Technology.
On the sell side, the largest reduction was First Trust NYSE Arca Biotechnology Index Fund, an estimated $10.7M trimmed.
- tru Independence's largest Q2 2020 buy was Bristol-Myers Squibb: 1,027,572 shares worth $19K.
- tru Independence added most to SPDR Gold Trust in Q2 2020, an estimated $9.38M increase.
- tru Independence's biggest Q2 2020 reduction was First Trust NYSE Arca Biotechnology Index Fund, cutting an estimated $10.7M.
- tru Independence fully exited Bristol-Myers Squibb Company Contingent Value Rights in Q2 2020, selling an estimated $49.3M.
- tru Independence's ten largest holdings make up 41% of its $691M portfolio in Q2 2020.
- tru Independence opened 207 new positions and closed 53 in Q2 2020.
- tru Independence's portfolio value rose 13% quarter-over-quarter to $691M.
Based on tru Independence's 13F filing for Q2 2020, filed 19 Aug 2020.